Intended for healthcare professionals

Corrections

A living WHO guideline on drugs for covid-19

BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1045 (Published 25 April 2022) Cite this as: BMJ 2022;377:o1045

This living guideline by Arnav Agarwal and colleagues (BMJ 2020;370:m3379, doi:10.1136/bmj.m3379) was last updated on 22 April 2022, but the infographic contained two dosing errors: the dose of ritonavir with renal failure should have read 100 mg, not 50 mg; and the suggested regimen for remdesivir should have been 3 days, not 5-10 days. The infographic has now been corrected.